Yarış atlarında kullanımı suistimal edilen bazı non-steroidal antienflamatuvar ilaçların biyolojik örneklerden kromatografik yöntemlerle miktar tayini

Year 2012, Volume: 16 Issue: 2, 91 - 106, 07.03.2014

Esra Tatar Sibel Topçu İlkay Küçükgüzel

Abstract

Dünya Anti-Doping Ajansı (WADA) tarafından hazırlanan ve güncellenen, yarışmalar
sırasında ve/veya serbest zamanlarda kullanımı yasaklı ilaç gruplarını ve yöntemlerini içeren
listelerde yer almayan, ancak atlarda kullanımı suistimal edilen bazı non-steroidal antienflamatuvar
ilaçların (asetilsalisilik asit, benzidamin, bufeksamak, diklofenak sodyum,
diflunisal, eltenak, etodolak, etorikoksib, felbinak, fenilbutazon, flufenamik asit, fluniksin,
flurbiprofen, ibuprofen, indometazin, indoprofen, karprofen, ketoprofen, ketorolak, meklofenamik
asit, mefenamik asit, meloksikam, mofebutazon, naproksen, niflumik asit, nimesulid,
oksifenbutazon, piroksikam, ramifenazon, selekoksib, sulindak, tenoksikam, tiaprofenik
asit, tolfenamik asit, tolmetin, valdekoksib ve vedaprofen) atlara ait biyolojik örneklerden
hareketle kromatografik yöntemlerle gerçekleştirilen nicel ve nitel analizleri ana hatları
ile derlenmiştir.

Keywords

ANAHTAR KELİMELER: Kromatografi, ilaç izlenmesi, non-steroidal antienflamatuvar ilaçlar, atlar

References

• Driessen B. Pain: Systemic and local/regional drug the- raphy. Clin Tech Equine Pract 2007; 6:135-44.
• Dirikolu L, Woods WE, Boyles J, Lehner AF, Harkins JD, Fischer M, Schaeffer DJ, Tobin T. Nonsteroidal an- ti-inflammatory agents and musculoskeletal injuries in thoroughbred racehorses in Kentucky. J Vet Pharmacol Therap 2008; 32:271-79.
• Bowers LD. The international antidoping system and why it works. Clin Chem 2009; 55:1456-61.
• National horsemen’s benevolent and protective associa- tion proposed national policy on drug testing and thera- peutic medication. J Equine Vet Sci 2003; 23:18-40.
• Nicolas-Frey H. International federation of horseracing authorities annual report on prohibited substance. PDF Dokümanı [Erişim Tarihi: 22 Şubat 2012; http://www. ifhaonline.org/resources/2007_Annual_doping_con- trol_annual_report.pdf]
• Erdine S. Ağrı. Nobel Tıp Kitabevleri Ltd. Şti., İstanbul, 2007.
• Yücel A, Çimen A. Nöropatik Ağrı: Mekanizmalar, tanı ve tedavi. Ağrı 2005; 17:5-13.
• Flecknell P. Analgesia from a veterinary perspective. Br J Anaesth 2008; 101:121-24.
• Muir WW. Pain: Mechanisms and management in hors- es. Vet Clin Equine 2010; 26:467-80.
• Kızıl Ö. Atlarda sancı ve sancılı atlarda muayene para- metreleri. FÜ Sağ Bil Derg 2007; 21:285-90.
• Kamerling S, Wood T, DeQuick D, Weckman TJ, Tai C, Blake JW, Tobin T. Narcotic analgesics, their detection and pain measurement in the horse: A review. Equine Vet J 1989; 21:4-12.
• Anti-Doping Eğitim ve Doping Kontrolünün Kanuni Yönleri. Editörler: Hıncal AA, Dalkara S, Hacettepe Üniversitesi ISBN 975-491-022-7, Ankara 1991, pp: 83-8.
• Maurer HH. Role of gas chromatography-mass spec- trometry with negative ion chemical ionization in clini- cal and forensic toxicology, doping control and biomoni- toring. Ther Drug Monit 2002; 24:247-54.
• Maurer HH. Systematic toxicological analysis proce- dures for acidic drugs and/or metabolites relevant to clinical and forensic toxicology and/or doping control. J Chromatogr B 1999; 733:3-25.
• Van Eenoo P, Delbeke FT. Criteria in chromatography and mass spectrometry-a comparison between regula- tions in the field of residue and doping analysis. Chro- matographia 2004; 59–Suppl.: 39-44.
• El Haj BM, Al Ainri AM, Hassan MH, Bin Khadem RK, Marzouq MS. The GC/MS analysis of some commonly used non-steroidal anti-inflammatory drugs (NSAIDs) in pharmaceutical dosage forms and in urine. For Sci Int 1999; 105:141-53.
• Segura J, Ventura R, Jurado C. Derivatization procedures for gas chromatographic-mass spectrometric determina- tion of xenobiotics in biological samples, with special at- tention to drugs of abuse and doping agents. J Chroma- togr B 1998; 713:61-90.
• Fragkaki AG, Leontiou IP, Kioukia-Fougia N, Tsivou M, Spyridaki MHE, Georgakopoulos CG. Organization of doping control laboratory in the Athens 2004 olympic games. A case study. Technovation 2006; 26:1162-69.
• Stanley SD, Kollias-Baker C. Review of equine drug test- ing. AAEP Proceedings 1997; 43:211-14.
• Thevis M, Schanzer W. Current role of LC-MS(/MS) in doping control. Anal Bioanal Chem 2007; 388:1351-58.
• Moulard Y, Bailly-Chouriberry L, Boyer S, Garcia P, Po- pot MA, Bonnaire Y. Use of benchtop exactive high reso- lution and high mass accuracy orbitrap mass spectrom- eter for screening in horse doping control. Anal Chim Acta 2011; 700:126-36.
• Peters RJB, Stloker AAM, Mol JGJ, Lommen A, Lyris E, Angelis Y, Vonaparti A, Stamou M, Georgakopoulos C, Nielen MWF. Screening in veterinary drug analysis and sports doping control based on full-scan, accurate-mass spectrometry. Trends in Anal Chem 2010; 29:1250-68.
• You Y, Uboh CE, Soma LR, Guan F, Li X, Liu Y, Chen J, Tsang D. Simultaneous determination of testosterone and testosterone enanthate in equine plasma by UHPLC- MS-MS. Chromatographia 2010; 72:1097-06.
• Vinci F, Fabbrocino S, Fiori M, Serpe L, Gallo P. Deter- mination of fourteen non-steroidal anti-inflammatory drugs in animal serum and plasma by liquid chromatog- raphy/mass spectrometry. Rapid Commun Mass Spec- trom 2006; 20:3412-20.
• DeJong EG, Kiffers J, Maes RAA. The determination of non-steroidal anti-inflammatory drugs by GC-MS-MS in equine urine. J Pharm Biomed Anal 1989; 7:1617-22.
• Singh AK, Jang Y, Mishra U, Granley K. Simultane- ous analysis of flunixin, naproxen, ethacrynic acid, in- domethacin, phenylbutazone, mefenamic acid and thi- osalicylic acid in plasma and urine by high-performance liquid chromatography and gas chromatography-mass spectrometry. J Chromatogr 1991; 568:351-61.
• Jaussaud P, Guieu D, Courtot D, Barbier B. Identification of a tolfenamic acid metabolite in the horse by gas chro- matography-mass spectrometry. J Chromatogr 1992; 573:136-40.
• Laakkonen UM, Leinonen A, Savonen L. Screening of non-steroidal anti-inflammatory drugs, barbiturates and methyl xanthines in equine urine by gas chromatogra- phy-mass spectrometry. Analyst 1994; 119:2695-96.
• Delbeke FT, Debackere M. A liquid chromatographic method for the determination of fenoprofen in equine plasma and urine. Biomed Chromatogr 1994; 8:29-31.
• Delbeke FT, Landuyt J, Debackere M. Disposition of hu- man drug preparations in the horse. IV. Orally adminis- tered fenoprofen. J Pharm Biomed Anal 1995; 13:1041-47.
• González G, Ventura R, Smith AK, de la Torre R, Segura J. Detection of non-steroidal anti-inflammatory drugs in equine plasma and urine by gas chromatography-mass spectrometry. J Chromatogr A 1996; 719:251-64.
• Tsitsimpikou C, Spyridaki MHE, Georgoulakis I, Koure- tas D, Konstantinidou M, Georgakopoulos CG. Elimina- tion profiles of flurbiprofen and its metabolites in equine urine doping analysis. Talanta 2001; 55:1173-80.
• Kim JY, Kim SJ, Paeng KJ, Chung BC. Measurement of ke- toprofen in horse urine using gas chromatography-mass spectrometry. J Vet Pharmacol Therap 2001; 24:315-19.
• Kvaternick V, Malinski T, Wortmann J, Fischer J. Quan- titative HPLC-UV method for the determination of firo- coxib from horse and dog plasma. J Chromatogr B 2007; 854:313-19.
• Wynne PM, Batty DC, Vine JH, Simpson NJK. Ap- proaches to the solid-phase extraction of equine urine. Chromatographia 2004; 59–Suppl.: 51-60.
• Spyridaki MHE, Lyris E, Georgoulakis I, Kouretas D, Konstantinidou M, Georgakopoulos CG. Determination of xylazine and its metabolites by GC-MS in equine urine for doping analysis. J Pharm Biomed Anal 2004; 35:107-16.
• Leung GNW, Chung EW, Ho ENM, Kwok WH, Leung DKK, Tang FPW, Wan TSM, Yu NH. High-throughput screening of corticosteroids and basic drugs in horse urine by liquid chromatography-tandem mass spec- trometry. J Chromatogr B 2005; 825:47-56.
• Machnik M, Due M, Parr M, von Kuk C, Schanzer W. Case study: Doping substances in equestrian food sup- plements. Chromatographia 2004; 59: 131-35.
• Leung GNW, Leung DKK, Wan TSM, Wong CHF. High- throughput screening sub-ppb levels of basic drugs in equine plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr A 2007; 1156:271-79.
• Cárdenas S, Gallego M, Valcárcel M, Ventura R, Segura J. A partially automated pretreatment module for routine analyses for seventeen non-steroid antiinflammatory drugs in race horses using gas chromatography/mass spectrometry. Anal Chem 1996; 68:118-23.
• Vonaparti A, Lyris E, Panderi I, Koupparis M, Georga- kopoulos C. Direct injection horse urine analysis for the quantification and identification of treshold substances for doping control.III. Determination of salicylic acid by liquid chromatography/quadrupole time-of-flight mass spectrometry. Anal Bioanal Chem 2009; 395:1403-10.
• Klaus AM, Schlingloff Y, Kleinitz U, Böttcher M, Hapke HJ. Pharmacokinetic study of dipyrone metabolite 4-MAA in the horse and possible implications for dop- ing control. J Vet Pharmacol Therap 1997; 20:204-08.
• Dyke TM, Sams RA, Cosgrove SB. Disposition of flunixin after intramuscular administration of flunixin meglumin to horses. J Vet Pharmacol Therap 1997; 20:330-32.
• Sinclair MD, Mealey KL, Matthews NS, Peck KE, Taylor TS, Bennett BS. Comparative pharmacokinetics of mel- oxicam in clinically normal horses and donkeys. Am J Vet Res 2006; 67:1082-85.
• Jaussaud P, Courtot D, Guyot JL, Paris J. Identification of a flunixin metabolite in the horse by gas chromatogra- phy-mass spectrometry. J Chromatogr 1987; 423:123-130.
• Sams RA, Gerken DF, Ashcraft SM. Detection and identi- fication of flunixin after multiple intravenous and intra- muscular doses to horses. J Anal Toxicol 1999; 23:372-79.
• Sabaté D, Homedes J, Salichs M, Sust M, Monreal L. Mul- ticentre, controlled, randomised and blinded field study comparing efficacy of suxibuzone and phenylbutazone in lame horses. Equine Vet J 2009; 41:700-5.
• Jaraiz MV, Dodriguez C, San Andres MD, Gonzalez F, San Andres MI. Disposition and tolerance of suxibuzone in horses. Equine Vet J 1999; 31:411-16.
• Delbeke FT, Baert K, De Backer P. Disposition of human drug preparations in the horse. VI. Tiaprofenic acid. J Chromatogr B 1997; 704:207-14.
• Marland A, Sarkar P, Leavitt R. The elimination profiles of tenoxicam and hydroxytenoxicam in equine urine and serum after a 200-mg oral dose. J Anal Toxicol 1999; 23:237-41.
• Koupai-Abyazani MR, Esaw B, Laviolette B. Etodolac in equine urine and serum: Determination by high- performance liquid chromatography with ultraviolet detection, confirmation and metabolite identification by atmospheric pressure ionization mass spectrometry. J Anal Toxicol 1999; 23:200-9.
• Marland A, Sarkar P, Leavitt R, Lee-Ruff E, Ramnauth J. The elimination profiles of oxaprozin in equine urine and serum after a 4.8-g oral dose. J Anal Toxicol 1999; 23:242-46.
• Goodrich LR, Nixon AJ. Medical treatment of osteoar- thritis in the horse - a review. Vet J 2006; 171: 51-69.
• Verde CR, Simpson MI, Frigoli A, Landoni MF. Enan- tiospecific pharmacokinetics of ketoprofen in plasma and synovial fluid of horses with acute synovitis. J Vet Pharmacol Ther 2001; 24:179-85.
• Aboul-Enein HY, Van Overbeke A, Vander Weken G, Baeyens W, Oda H, Deprez P, De Kruif A. HPLC on chiralcel OJ-R for enantiomer separation and analysis of ketoprofen, from horse plasma, as the 9-aminophenan- threne derivative. J Pharm Pharmacol 1998; 50:291-96.
• Baeyens WR, Van der Weken G, Haustraete J, Aboul- Enein HY, Corveleyn S, Remon JP, Garcia-Campaña AM, Deprez P. Application of the restricted-access precolumn packing material alkyl-diol silica in a column-switching system for the determination of ketoprofen enantiomers in horse plasma. J Chromatogr A 2000; 871:153-61.
• Baeyens WR, Van der Weken G, Haustraete J, Aboul- Enein HY, Corveleyn S, Remon JP, Garcia-Campaña AM, Deprez P. Direct HPLC analysis of ketoprofen in horse plasma applying an ADS-restricted access-phase. Biomed Chromatogr 1999; 13:450-54.
• Broome TA, Brown MP, Gronwall RR, Casey MF, Meritt KA. Pharmacokinetics and plasma concentrations of ace- tylsalicylic acid after intravenous, rectal and intragastric administration to horses. Can J Vet Res 2003; 67: 297-02.
• Van Eenoo P, Delbeke FT, Roels K, Baert K. Detection and disposition of tolmetin in the horse. J Pharm Biomed Anal 2003; 31:723-30.
• Dumasia MC, Morelli I, Teale P. Detection of eltenac in the horse: İdentification of phase I metabolites in urine by cap- illary gas chromatography-mass spectrometry and the de- termination of excretion profile by liquid chromatography- mass spectrometry. Chromatographia 2004; 59:115-21.
• Toutain PL, Reymond N, Laroute V, Garcia P, Popot MA, Bonnaire Y, Hirsch A, Narbe R. Pharmacokinetics of meloxicam in plasma and urine of horses. Am J Vet Res 2004; 65:1542-47.
• Tevell Aberg A, Olsson C, Bondesson U, Hedeland M. A mass spectrometric study on meloxicam metabolism in horses and the fungus Cunninghamella elegans and the relevance of this microbial system as a model of drug me- tabolism in the horse. J Mass Spectrom 2009; 44:1026-37.
• Baeyens WR, Van der Weken G, D’haeninck E, García- Campaña AM, Vankeirsbilck T, Vercauteren A, Deprez P. Application of an alkyl-diol silica precolumn in a col- umn-switching system for the determination of meloxi- cam in plasma. J Pharm Biomed Anal 2003; 32:839-46.
• Armstrong S, Tricklebank P, Lake A, Frean S, Lees P. Pharmacokinetics of carprofen enantiomers in equine plasma and synovial fluid–a comparison with ketopro- fen. J Vet Pharmacol Ther 1999; 22:196-01.
• Lees P, Landoni MF. Pharmacodynamics and enanti- oselective pharmacokinetics of racemic carprofen in the horse. J Vet Pharmacol Ther 2002; 25:433-48.
• Mealey KL, Matthews NS, Peck KE, Burchfield ML, Ben- nett BS, Taylor TS. Pharmacokinetics of R(-) and S(+) carprofen after administration of racemic carprofen in donkeys and horses. Am J Vet Res 2004; 65:1479-82.
• Yu J, Han KS, Lee G, Paik MJ, Kim KR. Enantiomeric com- position analysis of pranoprofen in equine plasma and urine by chiral liquid chromatography-tandem mass spec- trometry in selected reaction monitoring mode. J Chroma- togr B Analyt Technol Biomed Life Sci 2010; 878:3249-54.
• Letendre L, Kvaternick V, Tecle B, Fischer J. Automat- ed liquid chromatography-tandem mass spectrometry method for the analysis of firoxocib in urine and plasma from horse and dog. J Chromatogr B 2007; 853:333-45.
• Letendre LT, Tessman RK, McClure SR, Kvaternick VJ, Fischer JB, Hanson PD. Pharmacokinetics of firocoxib af- ter administration of multiple consecutive daily doses to horse. Am J Vet Res 2008; 69:1399-05.
• Yu NH, Ho ENM, Tang FPW, Wan TSM, Wong ASY. Comprehensive screening of acidic and neutral drugs in equine plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr A 2008; 1189:426-34.
• Davis JL, Marshall JF, Papich MG, Blikslager AT, Camp- bell NB. The pharmacokinetics and in vitro cyclooxyge- nase selectivity of deracoxib in horses. J Vet Pharmacol Ther 2011; 34:12-16.
• Barker SA. Drug contamination of the equine racetrack enviroment: a preliminary examination. J Vet Pharmacol Therap 2008; 31: 466-71.
• Mushoff F, Madea B. Analytical pitfalls in hair testing. Anal Bioanal Chem 2007; 388:1475-94.
• Dunnett M, Lees P. Hair analysis as a novel investigative tool for the detection of historical drug use/misuse in the horse: a pilot study. Equine Vet J 2004; 36:113-17.
• Dunnett M, Lees P. Trace element, toxin and drug elimi- nation in hair with particular reference to the horse. Res Vet Sci 2003; 75:89-101.
• Anielski P, Thieme D, Schlupp A, Grosse J, Ellendorff F, Mueller RK. Detection of testosterone, nandrolone and pre- cursors in horse hair. Anal Bioanal Chem 2005; 383:903-08.
• Anielski P. Hair analysis of anabolic steroids in connec- tion with doping control-results from horse samples. J Mass Spectrom 2008; 43: 1001-08.
• Soma LR, Uboh CE, Guan F, McDonnell S, Pack J. Phar- macokinetics of boldenone and stanozolol and the re- sults of quantification of anabolic and androgenic ster- oids in race horses and nonrace horses. J Vet Pharmacol Ther 2007; 30:101-08.
• Soma LR, Uboh CE, You Y, Guan F, McDonnell S. Plasma concentrations of testosterone and nandrolone in racing and nonracing intact male horses. J Vet Pharmacol Ther 2011; doi: 10.1111/j.1365-2885.2011.01295.x.
• Boyer S, Garcia P, Popot MA, Steiner V, Lesieur M. De- tection of testosterone propionate administration in horse hair samples. J Chromatogr B Analyt Technol Bi- omed Life Sci 2007; 852:684-88.
• Schlupp A, Anielski P, Thieme D, Müller RK, Meyer H, Ellendorff F. The beta-agonist clenbuterol in mane and tail hair of horses. Equine Vet J. 2004; 36:118-22.
• Popot MA, Boyer S, Maciejewski P, Garcia P, Bonnaire Y, Beyet L, Lesage D, Tabet JC. Determination of clen- buterol in horse hair by gas chromatography-tandem mass spectrometry. Chromatographia 2001; 53–Suppl.: 375-79.
• Jouvel C, Maciejewski P, Garcia P, Bonnaire Y, Horn- ing S, Popot MA. Detection of diazepam in horse hair samples by mass spectrometric methods. Analyst 2000; 125:1765-69.